Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

622 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of lercanidipine plus hydrochlorothiazide vs. lercanidipine plus enalapril on micro and macrocirculation in patients with mild essential hypertension.
De Ciuceis C, Salvetti M, Paini A, Rossini C, Muiesan ML, Duse S, Caletti S, Coschignano MA, Semeraro F, Trapletti V, Bertacchini F, Brami V, Petelca A, Agabiti Rosei E, Rizzoni D, Agabiti Rosei C. De Ciuceis C, et al. Among authors: salvetti m. Intern Emerg Med. 2017 Oct;12(7):963-974. doi: 10.1007/s11739-017-1696-7. Epub 2017 Jun 24. Intern Emerg Med. 2017. PMID: 28647890
Comparative effects of candesartan and enalapril on left ventricular hypertrophy in patients with essential hypertension: the candesartan assessment in the treatment of cardiac hypertrophy (CATCH) study.
Cuspidi C, Muiesan ML, Valagussa L, Salvetti M, Di Biagio C, Agabiti-Rosei E, Magnani B, Zanchetti A; CATCH investigators. Cuspidi C, et al. Among authors: salvetti m. J Hypertens. 2002 Nov;20(11):2293-300. doi: 10.1097/00004872-200211000-00030. J Hypertens. 2002. PMID: 12409969 Clinical Trial.
Effects of candesartan cilexetil and enalapril on inflammatory markers of atherosclerosis in hypertensive patients with non-insulin-dependent diabetes mellitus.
Rosei EA, Rizzoni D, Muiesan ML, Sleiman I, Salvetti M, Monteduro C, Porteri E; CENTRO (CandEsartaN on aTherosclerotic Risk factors) study investigators. Rosei EA, et al. Among authors: salvetti m. J Hypertens. 2005 Feb;23(2):435-44. doi: 10.1097/00004872-200502000-00027. J Hypertens. 2005. PMID: 15662233 Clinical Trial.
Effect of treatment with candesartan or enalapril on subcutaneous small artery structure in hypertensive patients with noninsulin-dependent diabetes mellitus.
Rizzoni D, Porteri E, De Ciuceis C, Sleiman I, Rodella L, Rezzani R, Paiardi S, Bianchi R, Ruggeri G, Boari GE, Muiesan ML, Salvetti M, Zani F, Miclini M, Rosei EA. Rizzoni D, et al. Among authors: salvetti m. Hypertension. 2005 Apr;45(4):659-65. doi: 10.1161/01.HYP.0000153308.91043.97. Epub 2005 Feb 21. Hypertension. 2005. PMID: 15723969 Clinical Trial.
622 results